Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 216Stomach Neoplasms 166Rectal Neoplasms 146Pancreatic Neoplasms 81Colonic Neoplasms 77Neoplasm Metastasis 67Esophageal Neoplasms 55Neoplasms 31Adenocarcinoma Of Esophagus 29Cholangiocarcinoma 28Carcinoma, Hepatocellular 26Adenocarcinoma 26Biliary Tract Neoplasms 23Lymphoma, Large B-Cell, Diffuse 19Recurrence 17Carcinoma, Non-Small-Cell Lung 16Gallbladder Neoplasms 14Breast Neoplasms 14Head and Neck Neoplasms 11Locally Advanced Rectal Cancer 10Liver Neoplasms 10Gastrointestinal Neoplasms 10Esophageal Squamous Cell Carcinoma 9Peritoneal Neoplasms 8Ovarian Neoplasms 8Colorectal Cancer Metastatic 7Bile Duct Neoplasms 6Urinary Bladder Neoplasms 5Lymphoma, Non-Hodgkin 5Lymphoma, Extranodal NK-T-Cell 5

Interventions

apatinib 3sintilimab 2Taxes 2Paclitaxel 2Oxaliplatin 2Hyperthermic Intraperitoneal Chemotherapy 2Albumin-Bound Paclitaxel 2trastuzumab deruxtecan 1taxane 1pembrolizumab 1durvalumab 1disitamab vedotin 1cabozantinib 1XELOX 1Tegafur 1Tadalafil 1SHR-1701 1S 1 (combination) 1Platinum 1Magnetic Resonance Spectroscopy 1Injections 1Gastrectomy 1Drug Therapy 1Drug Evaluation 1Docetaxel 1Cytoreduction Surgical Procedures 1Cisplatin 1Capecitabine 1Bevacizumab 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Gastric Adenocarcinoma × Oxaliplatin × Clear all
NCT07464756 2026-03-11

SHR-1701 With or Without Apatinib in Combination With Chemotherapy as Neoadjuvant Therapy for Gastric Cancer

The First Affiliated Hospital with Nanjing Medical University

Phase 2 Not yet recruiting
80 enrolled
Gastrointestinal

Gastric Adenocarcinoma

NCT06196697 2024-06-27

AK104 in Combination With AK112 Plus Chemotherapy(SOX/XELOX) as First-line Treatment for Advanced G/GEJ Cancer

Harbin Medical University

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Gastric Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡